Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000528545 | SCV000652191 | benign | Familial cold autoinflammatory syndrome 3 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001702804 | SCV002545818 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | PLCG2: BP4, BP7, BS1 |
ARUP Laboratories, |
RCV001702804 | SCV004562810 | benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004024219 | SCV005004682 | likely benign | Inborn genetic diseases | 2024-01-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001702804 | SCV005250692 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001702804 | SCV001927974 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702804 | SCV001973700 | likely benign | not provided | no assertion criteria provided | clinical testing |